Stocktoria

Genenta Science S.p.A. GNTA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-12-15 · LEI

Genenta Science S.p.A. statistics & valuation

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-36.90% -14.20% -27.20% -57.00% -71.30% -29.90% 202020212022202320242025
Shares outstanding
18.2M 18.2M 18.2M 18.2M 18.3M 23.4M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-32.00% -13.80% -25.40% -52.10% -60.10% -20.50% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.37 -$0.47 -$0.64 -$0.49 -$0.33 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-20.5%-60.1%-52.1%-25.4%-13.8%-32.0%
Return on equity-29.9%-71.3%-57.0%-27.2%-14.2%-36.9%
Current ratio14.166.8912.2514.5334.157.09

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.